Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Belani

Showing results (31-40 of 298) with videos related to

Pageof 30
Sort By:
Seminars in Oncology|August 7, 1999
Docetaxel (Taxotere) in combination with platinum-based regimens in non-small cell lung cancer: results and future developmentsC P Belani
Chest|April 25, 2000
Combined modality therapy for unresectable stage III non-small cell lung cancer: new chemotherapy combinationsC P Belani
Seminars in Oncology|October 18, 2001
Interim analysis of a phase II study of induction weekly paclitaxel/carboplatin regimens followed by maintenance weekly paclitaxel for advanced and metastatic non-small cell lung cancerC P Belani
Clinical Lung Cancer|June 26, 2004
Epidermal growth factor receptor mutations: a new insightChandra P Belani
Clinical Lung Cancer|January 11, 2005
Emerging role of erlotinib (OSI-774) in non-small-cell lung cancerChandra P Belani
Cancer Investigation|March 24, 2010
The role of irreversible EGFR inhibitors in the treatment of non-small cell lung cancer: overcoming resistance to reversible EGFR inhibitorsChandra P Belani
Clinical Lung Cancer|January 17, 2004
Chemotherapy regimens in advanced non small-cell lung cancer: recent randomized trialsC P Belani
Clinical Lung Cancer|January 15, 2004
Chemotherapy regimens in advanced non-small-cell lung cancer: recent randomized trialsChandra P Belani
Clinical Lung Cancer|January 22, 2004
Clinical lung cancer - a promising startC P Belani
Clinical Lung Cancer|November 6, 2003
Gefitinib for non-small cell lung cancer: is the efficacy real?Chandra P Belani
Pageof 30

Showing results (31-40 of 298) with videos related to

Sort By:
Pageof 30
Seminars in Oncology|August 7, 1999
Docetaxel (Taxotere) in combination with platinum-based regimens in non-small cell lung cancer: results and future developmentsC P Belani
Chest|April 25, 2000
Combined modality therapy for unresectable stage III non-small cell lung cancer: new chemotherapy combinationsC P Belani
Seminars in Oncology|October 18, 2001
Interim analysis of a phase II study of induction weekly paclitaxel/carboplatin regimens followed by maintenance weekly paclitaxel for advanced and metastatic non-small cell lung cancerC P Belani
Clinical Lung Cancer|June 26, 2004
Epidermal growth factor receptor mutations: a new insightChandra P Belani
Clinical Lung Cancer|January 11, 2005
Emerging role of erlotinib (OSI-774) in non-small-cell lung cancerChandra P Belani
Cancer Investigation|March 24, 2010
The role of irreversible EGFR inhibitors in the treatment of non-small cell lung cancer: overcoming resistance to reversible EGFR inhibitorsChandra P Belani
Clinical Lung Cancer|January 17, 2004
Chemotherapy regimens in advanced non small-cell lung cancer: recent randomized trialsC P Belani
Clinical Lung Cancer|January 15, 2004
Chemotherapy regimens in advanced non-small-cell lung cancer: recent randomized trialsChandra P Belani
Clinical Lung Cancer|January 22, 2004
Clinical lung cancer - a promising startC P Belani
Clinical Lung Cancer|November 6, 2003
Gefitinib for non-small cell lung cancer: is the efficacy real?Chandra P Belani
Pageof 30